サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1526355

ヘルスケアBPOの世界市場

Healthcare BPO
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 397 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
ヘルスケアBPOの世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 397 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアBPOの世界市場は2030年までに6,415億米ドルに達する

2023年に3,423億米ドルと推定されるヘルスケアBPOの世界市場は、2030年には6,415億米ドルに達すると予測され、分析期間2023-2030年のCAGRは9.4%で成長すると予測されます。本レポートで分析したセグメントの1つであるプロバイダーサービスは、CAGR 10.5%を記録し、分析期間終了時には2,348億米ドルに達すると予測されます。支払者サービス分野の成長率は、分析期間中CAGR 9.2%と推定されます。

米国市場は推定1,318億米ドル、中国はCAGR10.6%で成長予測

米国のヘルスケアBPO市場は、2023年に1,318億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに346億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.9%と7.9%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界のヘルスケアBPO市場- 主要動向と促進要因まとめ

ヘルスケアビジネスプロセスアウトソーシング（BPO）は、医療の質を維持・向上させながら業務の合理化とコスト削減を目指す医療提供者や組織にとって、不可欠な戦略となっています。この分野には、医療費の請求やコーディング、患者登録やスケジューリング、請求処理、収益サイクル管理などのサービスや、人事、ITサポート、サプライチェーン管理などの非臨床サービスが含まれます。これらの機能を専門のサービス・プロバイダーにアウトソーシングすることで、ヘルスケア機関は患者ケアや臨床業務により集中することができます。ヘルスケアBPOサービスに対する需要は、広範な管理・規制要件を伴うヘルスケアシステムの複雑さに支えられています。さらに、電子カルテ（EHR）や電子処方箋システムなどの新技術の導入により、医療機関よりもBPO企業の方が効率的に業務をこなす必要があります。

ヘルスケアBPOの進化はテクノロジーの進化と密接に結びついています。BPOサービスにおける人工知能（AI）と機械学習の統合は、請求、コーディング、クレーム管理などのプロセスの効率性と正確性を大幅に向上させました。反復的な作業を処理し、人的ミスを減らし、納期を改善するために、自動化技術の採用が増えています。データ分析もBPOプロバイダーが大きく進出している分野のひとつで、ヘルスケア組織が業務や患者サービスの最適化に活用できる実用的な洞察を提供しています。また、ヘルスケアBPOの世界な性質は、プロバイダーが多様な規制環境をナビゲートし、遵守しなければならないことを意味し、プロバイダーは専門知識とテクノロジーによって、患者データの取り扱いを規定する米国のHIPAAや欧州のGDPRのような法律の遵守を確実に管理します。

ヘルスケアBPO市場の成長は、医療の質を向上させながら運営コストを削減するという医療提供者への圧力の高まり、医療管理の複雑化、患者データのデジタル化の進行など、いくつかの要因によってもたらされます。また、各国のヘルスケア改革は、多くの場合、ケアの質と価格を向上させることを目的としており、BPOプロバイダーにとっては、コストを増大させることなく新たな規制基準に準拠しようとする機会を生み出しています。さらに、患者の満足度重視の高まりや、バリューベースのケアモデルへの移行に伴い、ヘルスケア・プロセスの効率的かつ効果的な管理が求められるようになり、専門的なBPOサービスの需要がさらに高まっています。また、機密性の高い医療データの安全かつコンプライアントな取り扱いを可能にする技術の進歩も、より多くの患者に効果的なサービスを提供しようとする世界・ヘルスケア・プロバイダーの拡大要件と同様に、市場の拡大に寄与しています。これらの要因によって、ヘルスケアBPOは現代のヘルスケアシステムの機能にとって極めて重要な、ダイナミックで進化し続ける分野となっています。

調査対象企業の例（全61件）

  • IBM Corporation
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd.
  • HCL Technologies Ltd.
  • Tata Consultancy Services Ltd.
  • Charles River Laboratories International, Inc.
  • Labcorp Drug Development
  • Tata Group
  • Concentrix Corporation
  • Genpact Ltd.
  • Hexaware Technologies Ltd.
  • Sykes Enterprises, Inc.
  • GeBBS Healthcare Solutions, Inc.
  • Catalent, Inc.
  • IQVIA

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP12285

Global Healthcare BPO Market to Reach US$641.5 Billion by 2030

The global market for Healthcare BPO estimated at US$342.3 Billion in the year 2023, is expected to reach US$641.5 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Provider Service, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$234.8 Billion by the end of the analysis period. Growth in the Payer Service segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$131.8 Billion While China is Forecast to Grow at 10.6% CAGR

The Healthcare BPO market in the U.S. is estimated at US$131.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$34.6 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.9% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Healthcare BPO Market - Key Trends & Drivers Summarized

Healthcare Business Process Outsourcing (BPO) has become an essential strategy for healthcare providers and organizations seeking to streamline operations and reduce costs while maintaining or enhancing the quality of care. This sector includes services such as medical billing and coding, patient enrollment and scheduling, claims processing, and revenue cycle management, as well as non-clinical services like human resources, IT support, and supply chain management. By outsourcing these functions to specialized service providers, healthcare institutions can focus more on patient care and clinical duties. The demand for healthcare BPO services is underpinned by the complexity of healthcare systems, which involve extensive administrative and regulatory requirements. Moreover, the adoption of new technologies such as Electronic Health Records (EHRs) and e-prescribing systems necessitates proficient handling that BPO firms can provide more efficiently than the healthcare providers themselves.

The evolution of healthcare BPO is closely tied to technological advancements. The integration of Artificial Intelligence (AI) and machine learning in BPO services has significantly enhanced the efficiency and accuracy of processes like billing, coding, and claims management. Automation technologies are increasingly employed to handle repetitive tasks, reducing human error and improving turnaround times. Data analytics is another area where BPO providers are making significant inroads, offering actionable insights that healthcare organizations can use to optimize their operations and patient services. The global nature of healthcare BPO also means that providers must navigate and comply with diverse regulatory environments, which they manage through expertise and technology, ensuring compliance with laws like HIPAA in the U.S. or GDPR in Europe, which govern the handling of patient data.

The growth in the healthcare BPO market is driven by several factors, including the rising pressure on healthcare providers to reduce operational costs while improving care quality, the increasing complexity of healthcare administration, and the ongoing digitization of patient data. Healthcare reforms across various countries, which often aim to increase the quality and affordability of care, also create opportunities for BPO providers as organizations seek to comply with new regulatory standards without escalating costs. Additionally, the growing focus on patient satisfaction and the shift towards value-based care models require efficient and effective management of healthcare processes, further bolstering the demand for specialized BPO services. The technological advancements that enable the secure and compliant handling of sensitive health data also contribute to the expansion of the market, as do the scaling requirements of global healthcare providers looking to serve more patients effectively. These drivers ensure that healthcare BPO remains a dynamic and evolving field, crucial to the functioning of modern healthcare systems.

Select Competitors (Total 61 Featured) -

  • IBM Corporation
  • Boehringer Ingelheim International GmbH
  • Lonza Group Ltd.
  • HCL Technologies Ltd.
  • Tata Consultancy Services Ltd.
  • Charles River Laboratories International, Inc.
  • Labcorp Drug Development
  • Tata Group
  • Concentrix Corporation
  • Genpact Ltd.
  • Hexaware Technologies Ltd.
  • Sykes Enterprises, Inc.
  • GeBBS Healthcare Solutions, Inc.
  • Catalent, Inc.
  • IQVIA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Outlook
    • Segment Review
    • Healthcare BPO - Global Key Competitors Percentage Market Share in 2024 (E)
    • Leading Players in the Global Contract Research Outsourcing Market by Revenue Share (in %): 2023
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Healthcare Costs to Drive Inclination towards BPO Services
    • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Aging Population Burdens an Already Strained Healthcare System: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Regulatory Challenges Inflate the Demand for Healthcare BPO
    • ICD-10 Coding Standards and Impending Adoption of ICD-11 Standards: Potential for BPO Providers
    • With Many Benefits of Cloud Computing, "The Cloud" Comes With a Silver Lining for BPO Service Providers Struggling to Remain Cost Competitive in the Era of Value Based Care
    • Inherent Advantages of Cloud Computing Make "The Cloud" a Game Changer in the Healthcare BPO Industry: Benefits of Cloud Measured in % Efficiency Improvements & Cost Reduction
    • Revenue Cycle Management Outsourcing Maximize Revenue Collection Operations
    • Global Market for Revenue Cycle Management: Revenues in US$ Billion for the Years 2018, 2020, 2022 and 2024
    • Reimbursement Changes Amplify Demand
    • Rise in Healthcare Industry Consolidation Boosts Growth Opportunities
    • Select M&A Deals Involving Large Healthcare Firms
    • Healthcare BPO Market for Pharma Sector
    • Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2024E
    • Patent Cliffs in Pharma Industry Drive Dependence on BPO Providers
    • Major Pharma Drugs Losing Patents
    • Healthcare Analytics Services Address the Challenge of High Data Volumes
    • Industry Witnesses a Surge in Near Shore Outsourcing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Provider Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Payer Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pharmaceutical Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Healthcare BPO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Rise in Healthcare Costs Trigger the Need for Healthcare BPO Services
    • Changing Regulations in the US: Implications for the Payer BPO Market
    • Rising Healthcare Costs Drive Healthcare Reforms in the US: Per Capita Healthcare Expenditure (in $) for the Period 2014-2019
    • Health Coverage in the US: Percentage Breakdown of Number of Americans Covered by Source of Health Coverage for the Years 2018 and 2028
    • Healthcare Reforms Lead to Reduced Uninsured Population: Percentage of Uninsured Population for the Period 2008, 2010, 2012, 2014, 2016 and 2018
    • Number of Medicare ACOs in the US for the Years 2012 through 2018
    • Market Analytics
    • TABLE 14: USA Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • JAPAN
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • CHINA
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Chinese Healthcare Industry on a Growth Trajectory
    • Market Analytics
    • TABLE 23: China Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • EUROPE
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • FRANCE
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • GERMANY
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Healthcare BPO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • Indian BPO Industry Revolutionizes Healthcare Sector
    • Market Analytics
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2014, 2024 & 2030

IV. COMPETITION